BIOMAT Database Logo BIOMAT Database Logo

Indirect sympathomimetics and cerebral blood flow and metabolism. 1977

J McCulloch, and V D Deshmukh, and A M Harper

UI MeSH Term Description Entries
D001812 Blood-Brain Barrier Specialized non-fenestrated tightly-joined ENDOTHELIAL CELLS with TIGHT JUNCTIONS that form a transport barrier for certain substances between the cerebral capillaries and the BRAIN tissue. Brain-Blood Barrier,Hemato-Encephalic Barrier,Barrier, Blood-Brain,Barrier, Brain-Blood,Barrier, Hemato-Encephalic,Barriers, Blood-Brain,Barriers, Brain-Blood,Barriers, Hemato-Encephalic,Blood Brain Barrier,Blood-Brain Barriers,Brain Blood Barrier,Brain-Blood Barriers,Hemato Encephalic Barrier,Hemato-Encephalic Barriers
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002560 Cerebrovascular Circulation The circulation of blood through the BLOOD VESSELS of the BRAIN. Brain Blood Flow,Regional Cerebral Blood Flow,Cerebral Blood Flow,Cerebral Circulation,Cerebral Perfusion Pressure,Circulation, Cerebrovascular,Blood Flow, Brain,Blood Flow, Cerebral,Brain Blood Flows,Cerebral Blood Flows,Cerebral Circulations,Cerebral Perfusion Pressures,Circulation, Cerebral,Flow, Brain Blood,Flow, Cerebral Blood,Perfusion Pressure, Cerebral,Pressure, Cerebral Perfusion
D000661 Amphetamine A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE. Desoxynorephedrin,Levoamphetamine,Phenopromin,l-Amphetamine,Amfetamine,Amphetamine Sulfate,Amphetamine Sulfate (2:1),Centramina,Fenamine,Mydrial,Phenamine,Thyramine,levo-Amphetamine,Sulfate, Amphetamine,l Amphetamine,levo Amphetamine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000882 Haplorhini A suborder of PRIMATES consisting of six families: CEBIDAE (some New World monkeys), ATELIDAE (some New World monkeys), CERCOPITHECIDAE (Old World monkeys), HYLOBATIDAE (gibbons and siamangs), CALLITRICHINAE (marmosets and tamarins), and HOMINIDAE (humans and great apes). Anthropoidea,Monkeys,Anthropoids,Monkey
D013566 Sympathomimetics Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters. Amines, Sympathomimetic,Sympathomimetic,Sympathomimetic Agent,Sympathomimetic Drug,Sympathomimetic Agents,Sympathomimetic Drugs,Sympathomimetic Effect,Sympathomimetic Effects,Agent, Sympathomimetic,Agents, Sympathomimetic,Drug, Sympathomimetic,Drugs, Sympathomimetic,Effect, Sympathomimetic,Effects, Sympathomimetic,Sympathomimetic Amines
D014439 Tyramine An indirect sympathomimetic that occurs naturally in cheese and other foods. Tyramine does not directly activate adrenergic receptors, but it can serve as a substrate for adrenergic uptake systems and MONOAMINE OXIDASE to prolong the actions of adrenergic transmitters. It also provokes transmitter release from adrenergic terminals and may be a neurotransmitter in some invertebrate nervous systems. 4-(2-Aminoethyl)phenol,4-Hydroxyphenethylamine,p-Tyramine,para-Tyramine,4 Hydroxyphenethylamine

Related Publications

J McCulloch, and V D Deshmukh, and A M Harper
Cerebral blood flow and cerebral metabolism.
January 1970, Triangle; the Sandoz journal of medical science,
J McCulloch, and V D Deshmukh, and A M Harper
Cerebral blood flow and metabolism.
January 1975, Ciba Foundation symposium,
J McCulloch, and V D Deshmukh, and A M Harper
Cerebral metabolism, cerebral blood flow and EEG.
January 1967, Electroencephalography and clinical neurophysiology,
J McCulloch, and V D Deshmukh, and A M Harper
Effects of hypercarbia on canine cerebral metabolism and blood flow with simultaneous direct and indirect measurement of blood flow.
June 1980, Anesthesiology,
J McCulloch, and V D Deshmukh, and A M Harper
Interactions between cerebral blood flow and cerebral metabolism.
January 1972, Surgical forum,
J McCulloch, and V D Deshmukh, and A M Harper
Cerebral blood flow and metabolism. Proceedings of the IXth International Symposium on Cerebral Blood Flow and Metabolism.
January 1980, Acta neurologica Scandinavica. Supplementum,
J McCulloch, and V D Deshmukh, and A M Harper
Cerebral blood flow and metabolism. Proceedings of the IXth International Symposium on Cerebral Blood Flow and Metabolism.
January 1979, Acta neurologica Scandinavica. Supplementum,
J McCulloch, and V D Deshmukh, and A M Harper
[Cerebral blood flow and metabolism in asymptomatic cerebral infarction].
November 2006, Nihon rinsho. Japanese journal of clinical medicine,
J McCulloch, and V D Deshmukh, and A M Harper
[Determination of cerebral blood flow and metabolism].
February 1985, Nihon rinsho. Japanese journal of clinical medicine,
J McCulloch, and V D Deshmukh, and A M Harper
Monitoring cerebral blood flow, metabolism and EEG.
December 1967, Electroencephalography and clinical neurophysiology,
Copied contents to your clipboard!